VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
McDonald's Corporation vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
McDonald's Corporation
MCD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into McDonald's Corporation's moat claims, evidence, and risks.
View MCD analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: McDonald's Corporation leads (80 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: McDonald's Corporation has 3 segments (48.7% in International Operated Markets); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: McDonald's Corporation has 5 moat types across 2 domains; Pfizer Inc. has 8 across 3.
Primary market context
McDonald's Corporation
International Operated Markets
Quick-service restaurants and informal eating out (IEO)
International operated markets (e.g., Australia, Canada, France, Germany, Italy, Poland, Spain, U.K.)
Consumers (end customers) and franchisees (B2B system partners)
Franchisor / restaurant operator
48.7%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
McDonald's Corporation strengths
Pfizer Inc. strengths
Segment mix
McDonald's Corporation segments
Full profile >U.S.
Competitive
International Operated Markets
Competitive
International Developmental Licensed Markets & Corporate
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.